Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.7 0 (0%) Market Cap: 2.45 Bil Enterprise Value: 4.93 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 62/100

Amneal Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 19, 2023 / 03:45PM GMT
Release Date Price: €1.47 (+20.49%)
Ami Fadia
Needham and Company - Analyst

Good morning, everyone. I'm Ami Fadia, one of the biotech analysts here at Needham. Thank you for joining the next session with Amneal Pharmaceuticals. It's my pleasure to be hosting Chirag Patel, Co-Founder and Co-CEO of the company.

I just wanted to remind our listeners that if you have any questions that you'd like me to ask the team, please forward it to me through the dashboard. And with that, Chirag, thank you so much for joining us today, and I'll turn it over to you for giving us the presentation on the company. And we'll have some time at the end for Q&A.

Chirag Patel
Amneal Pharmaceuticals, Inc. - President & Co-CEO

Thank you, Ami. Thank you for hosting us today. So happy to be here and nice to meet all of you virtually. Thank you. And our plan today was to present to you Amneal for first 20 minutes or so, and then give enough time for Q&A. So let me walk you through what Amneal is. Go to the next slides, please.

So I always start with how we began our journey. So in -- a very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot